Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
VYNE Therapeutics Inc. (VYNE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 Nov 2023
LEPORE PATRICK G
Director
VYNE Therapeutics Inc.
(VYNE)
36,472
+55%
13,000
$3.91
$50,778.00
BUY
20 Mar 2023
Harsch Mutya
Chief Legal Officer and GC, Officer
VYNE Therapeutics Inc.
(VYNE)
22,721
+78%
10,000
$2.50
$25,000.00
BUY
20 Mar 2023
LEPORE PATRICK G
Director
VYNE Therapeutics Inc.
(VYNE)
23,472
+576%
20,000
$2.48
$49,680.00
BUY
30 Nov 2021
LEPORE PATRICK G
Director
VYNE Therapeutics Inc.
(VYNE)
62,500
+25%
12,500
$1.02
$12,698.75
BUY
25 Aug 2021
LEPORE PATRICK G
Director
VYNE Therapeutics Inc.
(VYNE)
50,000
+33%
12,500
$1.60
$20,000.00
SELL
16 Aug 2021
PERCEPTIVE ADVISORS LLC
10% Owner
VYNE Therapeutics Inc.
(VYNE)
4,935,057
-4%
250,000
$1.74
$435,000.00
SELL
13 Aug 2021
PERCEPTIVE ADVISORS LLC
10% Owner
VYNE Therapeutics Inc.
(VYNE)
5,185,057
-4%
250,000
$1.84
$460,000.00
SELL
12 Aug 2021
PERCEPTIVE ADVISORS LLC
10% Owner
VYNE Therapeutics Inc.
(VYNE)
5,435,057
-5%
338,897
$2.23
$755,740.30
BUY
26 May 2021
LEPORE PATRICK G
Director
VYNE Therapeutics Inc.
(VYNE)
37,500
+50%
12,500
$3.60
$44,957.50
SELL
6 May 2021
PERCEPTIVE ADVISORS LLC
10% Owner
VYNE Therapeutics Inc.
(VYNE)
5,773,954
-14%
1,000,000
$3.67
$3,670,000.00
BUY
15 Mar 2021
LEPORE PATRICK G
Director
VYNE Therapeutics Inc.
(VYNE)
25,000
+100%
12,500
$7.41
$92,562.50
BUY
28 Jan 2021
PERCEPTIVE ADVISORS LLC
10% Owner
VYNE Therapeutics Inc.
(VYNE)
27,095,820
+4%
1,054,852.2
$9.48
$9,999,999.00
BUY
3 Dec 2020
LEPORE PATRICK G
Director
VYNE Therapeutics Inc.
(VYNE)
50,000
+33%
12,500
$6.83
$85,425.00
BUY
8 Sep 2020
Saik Andrew
Chief Financial Officer, Officer
VYNE Therapeutics Inc.
(VYNE)
340,000
+3%
10,000
$5.85
$58,480.00
BUY
8 Sep 2020
Domzalski David
President and CEO, Director, Officer
VYNE Therapeutics Inc.
(VYNE)
1,315,966
+1%
18,750
$5.52
$103,567.50
BUY
9 Jun 2020
PERCEPTIVE ADVISORS LLC
10% Owner
Menlo Therapeutics Inc.
(MNLO)
22,876,410
+3%
675,675.5
$7.40
$4,999,999.00
SELL
24 Jul 2018
Presidio Partners 2007 GP, L.P.
Former 10% Owner
Menlo Therapeutics Inc.
(MNLO)
1,907,568
-6%
125,000
$30.60
$3,825,000.00
BUY
25 Jan 2018
Vivo Capital VIII, LLC
10% Owner
Menlo Therapeutics, Inc.
(MNLO)
258,432
+39%
73,529.5
$68.00
$5,000,006.00
BUY
25 Jan 2018
Remeditex Ventures LLC
10% Owner
Menlo Therapeutics, Inc.
(MNLO)
1,582,854
+1%
25,000
$68.00
$1,700,000.00
BUY
25 Jan 2018
venBio Global Strategic Fund II L.P.
10% Owner
Menlo Therapeutics, Inc.
(MNLO)
265,000
+33%
66,250
$68.00
$4,505,000.00
BUY
25 Jan 2018
Cha Albert
Director
Menlo Therapeutics, Inc.
(MNLO)
258,432
+39%
73,529.5
$68.00
$5,000,006.00
Home